Clinical Trial Update: Efficacy and Safety of Metamizole Versus Placebo as Antithermic Therapy in the Acute Phase of Ischemic Stroke [Phase 4]

View source ↗

Summary

Phase 4 trial comparing metamizole to placebo as fever-reducing therapy in the acute phase of ischemic stroke was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Metamizole (metamizole)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Stroke | Phase 4 | Status: TERMINATED